For research use only. Not for use in humans.

Naptumomab (Anti-TPBG)

Synonyms: null Cat.No.A2941 Purity:99%

Naptumomab (Anti-TPBG) is a monoclonal antibody directed towards the tumor-associated oncofetal trophoblast glycoprotein antigen 5T4 with immunomodulating and antineoplastic activities. MW: 145.18 KD.

Naptumomab (Anti-TPBG)

Quality Control

Batch: A294101 Purity: 99% Protein concentration: 7.862mg/ml Endotoxin Level: ＜1EU/mg

99

Mechanism of Action

Description	Naptumomab (Anti-TPBG) is a monoclonal antibody directed towards the tumor-associated oncofetal trophoblast glycoprotein antigen 5T4 with immunomodulating and antineoplastic activities. MW: 145.18 KD.
References	https://pubmed.ncbi.nlm.nih.gov/20053143/

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID

Product Details

CAS No.	676258-98-3
Molecular Weight	145.18
Isotype	Human IgG1
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100 mM Pro-Ac, 20mM Arg, pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

^*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.